Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM3PT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,821
Award facts
- Contract value 100% obligated
- $13,821.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $13,821.21, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a firm fixed-price contract for DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products to support federal medical procurement needs. The contract was competitively awarded with no set-aside designation and is scheduled for completion by February 2, 2026. The Defense Logistics Agency, which funds this award, procures pharmaceutical and medical supplies to support military healthcare operations globally. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters and pharmaceutical distribution operations. DUPIXENT is a prescription medication used in the treatment of various inflammatory conditions, and this order represents one of numerous delivery orders Amerisourcebergen fulfills under its DLA prime vendor contract. As a major pharmaceutical distributor, Amerisourcebergen demonstrates consistent capability to meet federal procurement requirements through competitive bidding across multiple therapeutic domains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM3PT?
SPE2DR26FM3PT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FM3PT worth?
The government has obligated $13,821 on SPE2DR26FM3PT.
Is contract SPE2DR26FM3PT an order under another contract?
Yes. SPE2DR26FM3PT is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3PT competed?
The extent of competition for SPE2DR26FM3PT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award